Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension

S PARK; N CHUNG; J KWON; J YOON; Y KIM; D HAN; H KIM

doi:10.1016/j.clinthera.2005.04.001

Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.04.001 ◽

2005 ◽

Vol 27 (4) ◽

pp. 441-450 ◽

Cited By ~ 12

Author(s):

S PARK ◽

N CHUNG ◽

J KWON ◽

J YOON ◽

Y KIM ◽

...

Keyword(s):

Clinical Trial ◽

Moderate Hypertension ◽

Phase Iii ◽

Amlodipine Besylate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Korean Patients ◽

Parallel Group

Download Full-text

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.05.013 ◽

2008 ◽

Vol 30 (5) ◽

pp. 845-857 ◽

Cited By ~ 11

Author(s):

Sung Ai Kim ◽

Sungha Park ◽

Namsik Chung ◽

Do-Sun Lim ◽

Joo-Young Yang ◽

...

Keyword(s):

Clinical Trial ◽

Moderate Hypertension ◽

Phase Iii ◽

Efficacy And Safety ◽

Amlodipine Besylate ◽

Double Blind ◽

Korean Patients ◽

Parallel Group

Download Full-text

Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in korean adults with mild to moderate hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.09.018 ◽

2007 ◽

Vol 29 (9) ◽

pp. 1924-1936 ◽

Cited By ~ 6

Author(s):

S KIM ◽

Y KIM ◽

D LIM ◽

M YOON ◽

Y AHN ◽

...

Keyword(s):

Clinical Trial ◽

Moderate Hypertension ◽

Phase Iii ◽

Amlodipine Besylate ◽

Double Blind ◽

Korean Adults ◽

Parallel Group

Download Full-text

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of [Sucrose gel for treatment of bacterial vaginosis: a randomized, double-blind, multi-center, parallel-group, phase III clinical trial].

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731206699.793536794 ◽

2017 ◽

Author(s):

Phillip Hay

Keyword(s):

Clinical Trial ◽

Bacterial Vaginosis ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.01.024 ◽

2012 ◽

Vol 34 (3) ◽

pp. 552-568.e9 ◽

Cited By ~ 34

Author(s):

Sang Eun Lee ◽

Yong-Jin Kim ◽

Hae-Young Lee ◽

Han-Mo Yang ◽

Chang-Gyu Park ◽

...

Keyword(s):

Clinical Trial ◽

Dose Escalation ◽

Angiotensin Receptor Blocker ◽

Moderate Hypertension ◽

Phase Iii ◽

Receptor Blocker ◽

Extension Phase ◽

Angiotensin Receptor ◽

Double Blind ◽

Parallel Group

Download Full-text

Quantification of Pedal Edema During Treatment With S(-)-Amlodipine Nicotinate Versus Amlodipine Besylate in Female Korean Patients With Mild to Moderate Hypertension: A 12-Week, Multicenter, Randomized, Double-Blind, Active-Controlled, Phase IV Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.08.003 ◽

2012 ◽

Vol 34 (9) ◽

pp. 1940-1947 ◽

Cited By ~ 8

Author(s):

Gyu-Chul Oh ◽

Hae-Young Lee ◽

Hyun-Jae Kang ◽

Joo-Hee Zo ◽

Dong-Ju Choi ◽

...

Keyword(s):

Clinical Trial ◽

Moderate Hypertension ◽

Amlodipine Besylate ◽

Double Blind ◽

Korean Patients ◽

Pedal Edema ◽

Phase Iv

Download Full-text

Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12435 ◽

2015 ◽

Vol 17 (6) ◽

pp. 599-602 ◽

Cited By ~ 23

Author(s):

S.‐M. Jin ◽

C.‐Y. Park ◽

Y. M. Cho ◽

B. J. Ku ◽

C. W. Ahn ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text